Moreover, treatment with the novel KDM1A antagonist significantly improved the survival of murine model of human AML, with inducing differentiation and apoptosis of leukemic cells.31 These results suggest that KDM1A may be related with maintenance of leukemic cell as an epigenetic regulator. Here, KDM1A is linked to acute myeloid leukemia.